News Celestial Therapeutics 10/15/24 Celestial Therapeutics 10/15/24 Celestial Therapeutics Joins the Mayo Clinic Innovation Exchange Read More Celestial Therapeutics 6/13/23 Celestial Therapeutics 6/13/23 CEPI Partners with Celestial Therapeutics Inc to Develop Self-Adjuvanting mRNA Vaccine Platform Read More Celestial Therapeutics 5/8/23 Celestial Therapeutics 5/8/23 Celestial Therapeutics Announces SBIR Fast Track Grant Award Read More Celestial Therapeutics 2/15/22 Celestial Therapeutics 2/15/22 Cornell University’s Red Bear Angels Invests in Celestial Therapeutics Read More Celestial Therapeutics 10/28/21 Celestial Therapeutics 10/28/21 Renowned Geneticist Dr. George Church Joins Celestial Therapeutics Scientific Advisory Board Read More Celestial Therapeutics 10/1/21 Celestial Therapeutics 10/1/21 Celestial Therapeutics Licenses Novel mRNA Platform Technology From Harvard to Develop Next Generation Vaccines and Therapeutics Read More Celestial Therapeutics 9/29/21 Celestial Therapeutics 9/29/21 Celestial Therapeutics Selected to Present at the 2021 MedTech Innovation Forum Read More Celestial Therapeutics 9/27/21 Celestial Therapeutics 9/27/21 Celestial Therapeutics Accepted into NYU’s Endless Frontier Labs Startup Accelerator Read More Celestial Therapeutics 5/14/21 Celestial Therapeutics 5/14/21 Nobel Laureate Dr. Michael Houghton joins Celestial Therapeutics Scientific Advisory Board Read More Celestial Therapeutics 4/21/21 Celestial Therapeutics 4/21/21 Celestial Therapeutics Accepted into the Prestigious StartX Med Accelerator Program Read More
Celestial Therapeutics 10/15/24 Celestial Therapeutics 10/15/24 Celestial Therapeutics Joins the Mayo Clinic Innovation Exchange Read More
Celestial Therapeutics 6/13/23 Celestial Therapeutics 6/13/23 CEPI Partners with Celestial Therapeutics Inc to Develop Self-Adjuvanting mRNA Vaccine Platform Read More
Celestial Therapeutics 5/8/23 Celestial Therapeutics 5/8/23 Celestial Therapeutics Announces SBIR Fast Track Grant Award Read More
Celestial Therapeutics 2/15/22 Celestial Therapeutics 2/15/22 Cornell University’s Red Bear Angels Invests in Celestial Therapeutics Read More
Celestial Therapeutics 10/28/21 Celestial Therapeutics 10/28/21 Renowned Geneticist Dr. George Church Joins Celestial Therapeutics Scientific Advisory Board Read More
Celestial Therapeutics 10/1/21 Celestial Therapeutics 10/1/21 Celestial Therapeutics Licenses Novel mRNA Platform Technology From Harvard to Develop Next Generation Vaccines and Therapeutics Read More
Celestial Therapeutics 9/29/21 Celestial Therapeutics 9/29/21 Celestial Therapeutics Selected to Present at the 2021 MedTech Innovation Forum Read More
Celestial Therapeutics 9/27/21 Celestial Therapeutics 9/27/21 Celestial Therapeutics Accepted into NYU’s Endless Frontier Labs Startup Accelerator Read More
Celestial Therapeutics 5/14/21 Celestial Therapeutics 5/14/21 Nobel Laureate Dr. Michael Houghton joins Celestial Therapeutics Scientific Advisory Board Read More
Celestial Therapeutics 4/21/21 Celestial Therapeutics 4/21/21 Celestial Therapeutics Accepted into the Prestigious StartX Med Accelerator Program Read More
